Drägerwerk AG & Co. KGaA (OTCMKTS:DGWPF – Get Free Report) is one of 131 publicly-traded companies in the “Medical Devices” industry, but how does it contrast to its peers? We will compare Drägerwerk AG & Co. KGaA to similar businesses based on the strength of its institutional ownership, valuation, analyst recommendations, risk, earnings, dividends and profitability.
Analyst Ratings
This is a breakdown of current recommendations for Drägerwerk AG & Co. KGaA and its peers, as reported by MarketBeat.com.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Drägerwerk AG & Co. KGaA | 1 | 0 | 0 | 0 | 1.00 |
Drägerwerk AG & Co. KGaA Competitors | 199 | 1058 | 1185 | 86 | 2.46 |
As a group, “Medical Devices” companies have a potential upside of 87.82%. Given Drägerwerk AG & Co. KGaA’s peers stronger consensus rating and higher probable upside, analysts clearly believe Drägerwerk AG & Co. KGaA has less favorable growth aspects than its peers.
Insider & Institutional Ownership
Profitability
This table compares Drägerwerk AG & Co. KGaA and its peers’ net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Drägerwerk AG & Co. KGaA | N/A | N/A | N/A |
Drägerwerk AG & Co. KGaA Competitors | -63.94% | -37.59% | -15.82% |
Earnings & Valuation
This table compares Drägerwerk AG & Co. KGaA and its peers revenue, earnings per share and valuation.
Gross Revenue | Net Income | Price/Earnings Ratio | |
Drägerwerk AG & Co. KGaA | N/A | N/A | 7.18 |
Drägerwerk AG & Co. KGaA Competitors | $488.80 million | $18.23 million | 75.74 |
Drägerwerk AG & Co. KGaA’s peers have higher revenue and earnings than Drägerwerk AG & Co. KGaA. Drägerwerk AG & Co. KGaA is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.
Summary
Drägerwerk AG & Co. KGaA peers beat Drägerwerk AG & Co. KGaA on 8 of the 11 factors compared.
Drägerwerk AG & Co. KGaA Company Profile
Drägerwerk AG & Co. KGaA operates as a medical and safety technology company in Europe, the Americas, Africa, Asia, and Australia. It develops, produces, and markets system solutions, equipment, and services for acute point of care, including emergency care, perioperative care, critical care, and perinatal care. The company also develops, produces, and markets products, system solutions, and services for personal protection, gas detection technology, and integrated hazard management to customers in industry and mining sectors, as well as public sectors, such as fire departments, police, and disaster protection. Its products portfolio includes anesthesia devices and ventilators, thermoregulation equipment, consumables and accessories, supply units, lights, gas management systems, patient monitoring, software applications, system products, and other services. The company's product portfolio also comprises stationary and mobile gas detection systems, personal protective equipment, and alcohol and drug testing devices. In addition, it offers various training and services, as well as fire training facilities for firefighters. The company was founded in 1889 and is headquartered in Lübeck, Germany. Drägerwerk AG & Co. KGaA operates as a subsidiary of Stefan DrÄGer Gmbh.
Receive News & Ratings for Drägerwerk AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Drägerwerk AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.